Related references
Note: Only part of the references are listed.An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis
Semra Palic et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Evaluation of systemic immunity in atypical cutaneous leishmaniasis caused by Leishmania (L.) infantum chagasi
Marcia Dalastra Laurenti et al.
PARASITE IMMUNOLOGY (2022)
In vitro anti-Leishmania activity of 8-hydroxyquinoline and its synergistic effect with amphotericin B deoxycholate against Leishmania martiniquensis
Wetpisit Chanmol et al.
PEERJ (2022)
Treatment options for leishmaniasis
S. Pradhan et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)
Parasitological and immunological evaluation of a quinoline derivative salt incorporated into a polymeric micelle formulation against Leishmania infantum infection
Luciana M. Ribeiro Antinarelli et al.
PARASITOLOGY RESEARCH (2022)
Conundrums in leishmaniasis
Baibaswata Saha et al.
CYTOKINE (2021)
Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships
Ojasvi Gupta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Insights of 8-hydroxyquinolines: A novel target in medicinal chemistry
Rohini Gupta et al.
BIOORGANIC CHEMISTRY (2021)
Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent
Deepender Kaushik et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2021)
Leishmanicidal Activity and Ultrastructural Changes of Maslinic Acid Isolated from Hyptidendron canum
Jessica Adriana Jesus et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2021)
The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis
Luiz Felipe D. Passero et al.
FRONTIERS IN PHARMACOLOGY (2021)
Cutaneous leishmaniasis: A great imitator
Mehmet Salih Gurel et al.
CLINICS IN DERMATOLOGY (2020)
8-Hydroxyquinoline-5-sulfonamides are promising antifungal candidates for the topical treatment of dermatomycosis
B. Pippi et al.
JOURNAL OF APPLIED MICROBIOLOGY (2020)
The Geographical Distribution of Cutaneous Leishmaniasis Causative Agents in Iran and Its Neighboring Countries, A Review
Mohammad Amin Ghatee et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases
Theo Battista et al.
MOLECULES (2020)
Tolnaftate inhibits ergosterol production and impacts cell viability of Leishmania sp.
Eduardo Seiji Yamamoto et al.
BIOORGANIC CHEMISTRY (2020)
Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
Jessica Adriana Jesus et al.
PATHOGENS (2020)
Antileishmanial activity of synthetic analogs of the naturally occurring quinolone alkaloid N-methyl-8-methoxyflindersin
Elaine Torres Suarez et al.
PLOS ONE (2020)
A clioquinol-containing Pluronic(R) F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model
Grasiele S. V. Tavares et al.
PARASITE (2020)
Visceral Leishmaniasis Recent Advances in Diagnostics and Treatment Regimens
Johan van Griensven et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection
Grasiele S. V. Tavares et al.
PARASITOLOGY INTERNATIONAL (2019)
Current and emerging medications for the treatment of leishmaniasis
Jaya Chakravarty et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
What makes mucosal and anergic diffuse cutaneous leishmaniases so clinically and immunopathogically different? A review in Brazil
Fernando T. Silveiraa
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2019)
Leishmaniasis and various immunotherapeutic approaches
Y. Taslimi et al.
PARASITOLOGY (2018)
Leishmaniasis in humans: drug or vaccine therapy?
Masoud Ghorbani et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review
Vincent Mosimann et al.
ACTA TROPICA (2018)
Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species
Grasiele de Sousa Vieira Tavares et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Emerging therapeutic targets for treatment of leishmaniasis
Shyam Sundar et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors
Andrea Ilari et al.
MOLECULAR PHARMACEUTICS (2018)
Synthesis, leishmanicidal activity, structural descriptors and structure-activity relationship of quinoline derivatives
Etyene J. G. Silva et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
Saumya Srivastava et al.
PARASITES & VECTORS (2017)
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Alicia Ponte-Sucre et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Quin line derivatives: Synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action
Elaine S. Coimbra et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system
Mariana Costa Duarte et al.
PARASITOLOGY INTERNATIONAL (2016)
An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis
Leticia Martins dos Reis Lage et al.
PARASITOLOGY RESEARCH (2016)
An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis
Mariana Costa Duarte et al.
VETERINARY PARASITOLOGY (2016)
Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions
Fernando Real et al.
CELLULAR MICROBIOLOGY (2014)
The potential of quinoline derivatives for the treatment of Toxoplasma gondii infection
Dema Kadri et al.
EXPERIMENTAL PARASITOLOGY (2014)
Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
Richard J. Hamill
DRUGS (2013)
In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni
Gamal Allam et al.
PARASITOLOGY RESEARCH (2013)
Challenges in the Therapy of Visceral Leishmaniasis in Brazil: A Public Health Perspective
Edson Carvalho de Melo et al.
JOURNAL OF TROPICAL MEDICINE (2013)
Visceral Leishmaniasis
Johan van Griensven et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2012)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation
Luiz Felipe D. Passero et al.
PARASITES & VECTORS (2012)
Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World
Luiz F. Oliveira et al.
ACTA TROPICA (2011)
Antimony Toxicity
Shyam Sundar et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2010)
Molecular Basis of Antimony Treatment in Leishmaniasis
Paola Baiocco et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Pentavalent Antimonials: New Perspectives for Old Drugs
Frederic Frezard et al.
MOLECULES (2009)
Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis
F. T. Silveira et al.
PARASITE IMMUNOLOGY (2009)
In vitro infectivity of species of Leishmania (Viannia) responsible for American cutaneous leishmaniasis
Marliane Batista Campos et al.
PARASITOLOGY RESEARCH (2008)
Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide
Rami M. Mukbel et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Cutaneous leishmaniasis
Richard Reithinger et al.
LANCET INFECTIOUS DISEASES (2007)
Infection-induced respiratory burst in BALB/c macrophages kills Leishmania guyanensis amastigotes through apoptosis:: possible involvement in resistance to cutaneous leishmaniasis
J Sousa-Franco et al.
MICROBES AND INFECTION (2006)
Share Paper
